NWMP
TGTX icon

Noble Wealth Management PBC’s TG Therapeutics TGTX Stock Holding History

Noble Wealth Management PBC’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45.7K Sell
820
-20
-2% -$1.08K 0.02% 268
2026
Q2 		$46.1K Buy
840
+15
+2% +$614 0.02% 282
2026
Q1 		$27.4K Hold
825
– – 0.01% 334
2025
Q4 		$24.6K Sell
825
-75
-8% -$2.45K 0.01% 352
2025
Q3 		$32.5K Buy
+900
New +$29.6K 0.02% 300

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Noble Wealth Management PBC's TGTX Position: Q3 2026 in Review

Noble Wealth Management PBC reduced its TG Therapeutics (TGTX) stake by 2.4% in Q3 2026, selling an estimated $1.08K and leaving 820 shares worth $45.7K. The position accounts for 0.02% of the portfolio, ranked #268.

Noble Wealth Management PBC first reported a position in TGTX in Q3 2025 and has held it in 5 quarters since. The position peaked at $46.1K in Q2 2026. 12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Noble Wealth Management PBC held 820 shares of TG Therapeutics worth $45.7K as of Q3 2026.
  • Noble Wealth Management PBC sold 20 TG Therapeutics shares in Q3 2026, an estimated $1.08K.
  • TG Therapeutics made up 0.02% of Noble Wealth Management PBC's portfolio in Q3 2026, its #268 holding.
  • Noble Wealth Management PBC first reported a position in TG Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Noble Wealth Management PBC's TG Therapeutics position peaked at $46.1K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.